Delayed
OTC Markets
01:08:34 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.0001
USD
|
+9,900.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
8.953
|
4.616
|
3.053
|
1.051
|
1.434
|
1.761
|
Enterprise Value (EV)
1 |
10.85
|
5.366
|
4.441
|
6.336
|
5.869
|
6.347
|
P/E ratio
|
-1.2
x
|
-0.33
x
|
-0.29
x
|
-0.28
x
|
-0.32
x
|
-7.61
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
23.9
x
|
3.1
x
|
2.1
x
|
0.64
x
|
1.13
x
|
2.29
x
|
EV / Revenue
|
29
x
|
3.61
x
|
3.05
x
|
3.85
x
|
4.64
x
|
8.26
x
|
EV / EBITDA
|
-1.89
x
|
-0.97
x
|
-1.74
x
|
-2.99
x
|
-8.84
x
|
-
|
EV / FCF
|
7
x
|
1.78
x
|
4.49
x
|
-231
x
|
8.79
x
|
-1.53
x
|
FCF Yield
|
14.3%
|
56.2%
|
22.3%
|
-0.43%
|
11.4%
|
-65.5%
|
Price to Book
|
-2.72
x
|
-1.82
x
|
-0.45
x
|
-0.17
x
|
-0.14
x
|
-0.24
x
|
Nbr of stocks (in thousands)
|
2,238
|
3,037
|
23,045
|
85,473
|
2,17,271
|
2,51,593
|
Reference price
2 |
4.000
|
1.520
|
0.1325
|
0.0123
|
0.006600
|
0.007000
|
Announcement Date
|
03/05/17
|
17/04/18
|
16/04/19
|
02/06/20
|
12/04/21
|
15/04/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
1 |
0.3742
|
1.487
|
1.457
|
1.646
|
1.265
|
0.7685
|
EBITDA
1 |
-5.749
|
-5.525
|
-2.55
|
-2.117
|
-0.664
|
-
|
EBIT
1 |
-5.759
|
-5.982
|
-3.049
|
-2.257
|
-0.8036
|
-0.7488
|
Operating Margin
|
-1,539.07%
|
-402.31%
|
-209.25%
|
-137.08%
|
-63.52%
|
-97.44%
|
Earnings before Tax (EBT)
1 |
-7.067
|
-14.65
|
-6.905
|
-2.571
|
-3
|
2.972
|
Net income
1 |
-7.067
|
-14.65
|
-6.905
|
-2.571
|
-3
|
2.972
|
Net margin
|
-1,888.58%
|
-985.2%
|
-473.94%
|
-156.16%
|
-237.16%
|
386.72%
|
EPS
2 |
-3.330
|
-4.670
|
-0.4513
|
-0.0437
|
-0.0208
|
-0.000920
|
Free Cash Flow
1 |
1.552
|
3.013
|
0.9892
|
-0.0274
|
0.6681
|
-4.155
|
FCF margin
|
414.64%
|
202.64%
|
67.89%
|
-1.66%
|
52.81%
|
-540.6%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
03/05/17
|
17/04/18
|
16/04/19
|
02/06/20
|
12/04/21
|
15/04/22
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
1.9
|
0.75
|
1.39
|
5.28
|
4.44
|
4.59
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.3306
x
|
-0.1358
x
|
-0.544
x
|
-2.496
x
|
-6.68
x
|
-
|
Free Cash Flow
1 |
1.55
|
3.01
|
0.99
|
-0.03
|
0.67
|
-4.15
|
ROE (net income / shareholders' equity)
|
311%
|
307%
|
99.4%
|
30.9%
|
31.8%
|
-33.1%
|
ROA (Net income/ Total Assets)
|
-191%
|
-266%
|
-179%
|
-49.6%
|
-13%
|
-16.2%
|
Assets
1 |
3.7
|
5.516
|
3.861
|
5.182
|
23.04
|
-18.37
|
Book Value Per Share
2 |
-1.470
|
-0.8300
|
-0.2900
|
-0.0700
|
-0.0500
|
-0.0300
|
Cash Flow per Share
2 |
0.0200
|
0.0200
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
03/05/17
|
17/04/18
|
16/04/19
|
02/06/20
|
12/04/21
|
15/04/22
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 26.87T | | +25.68% | 8.92TCr | | -26.60% | 7.61TCr | | +1.62% | 2.71TCr | | -10.63% | 1.71TCr | | -0.04% | 1.68TCr | | +0.60% | 1.54TCr | | +77.68% | 1.37TCr | | +78.51% | 1.33TCr | | -25.79% | 1.28TCr |
Other Healthcare Facilities & Services
|